Semler Scientific Hits 52-Week Low at $19.54 Amid Ongoing Decline

Semler Scientific, Inc., a microcap company in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 19.54 on November 19, 2025. This significant decline reflects a challenging year for the company, which has seen its stock price drop by 45.62% over the past year, contrasting sharply with the S&P 500's performance of 12.28% during the same period.
The company's market capitalization stands at USD 425 million, with a price-to-earnings ratio of 24.00. Semler Scientific has not offered a dividend, and its debt-to-equity ratio is reported at -0.04, indicating a unique financial structure. The return on equity is relatively low at 3.43%, and the price-to-book ratio is 1.11.

Semler has faced difficulties in its financial results, reporting negative outcomes for the last four consecutive quarters. Key metrics such as operating cash flow and net sales have also reached their lowest points, contributing to the stock's underperformance. The stock's previous 52-week high was USD 81.56, highlighting the extent of its recent decline.